NCT05833126 2023-12-15
Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation
Third Affiliated Hospital, Sun Yat-Sen University
Phase 2 Unknown